In view of the current development it is all the more important to restructure the board and fill it with people of high integrity and stat...

Nilekani's return will coincide with a major recast of the Infosys board, with mounting pressure on at least four members to step down.

Balakrishnan argued that Nilekani had "done well" during his tenure at Infosys and had been well connected with customers.

Talking about the Rs 13,000-crore buyback announced by the company, Balakrishnan said the timing was "unusual" with the CEO's resignation b...

Infosys is likely to pick an insider to succeed CEO Vishal Sikka, who resigned after three years on the job, leaving the board with a task ...

"Checks and balances are required in every company, and I was only doing that,” Murthy said.

Earlier this year, Ravi Venkatesan, a former Microsoft Corp. India chairman, was asked to mend fences between the board and CEO on one side...

Venkatesan said he regards Murthy not only as the founder, but a mentor, and hoped that the relationship with him continues in a constructi...

Venkatesan said that bringing promoters and management together is "doable" and he spends four to five days in a week on this despite being...

The appointment is based on the recommendations of the Nomination and Remuneration Committee of the Board, Infosys said in a statement.

The revenue target of $20 bn was set by Sikka in fiscal 2015 but slowing industry growth and the company's own challenges have made it a ha...

"I must clarify saying Ravi's name did not come from the promoters. We don't need somebody else introducing Ravi to the board," says Seshas...

Ravi Venkatesan would likely take the lead in matters of strategy while Seshasayee would be responsible for governance and talking to inves...

President Pranab Mukherjee today gave away Presidential awards for Classical Tamil for the years 2011-2012 and 2012-13 in New Delhi.

Karunanidhi terms it improper to run a democratic assembly without an opposition. Feels the six erring DMK MLAs should be pardoned.

Venkatesan is bullish on the healthcare data analytics firm offering genetics-based treatment, which he believes will transform cancer trea...

Ann Fudge, Jeffrey Lehman and Ravi Venkatesan are tasked with recommending candidates for the post of CEO.